The Insider Activity Of Dynavax Technologies Corporation (DVAX) Is Worth Monitoring

Business man trader investor analyst using mobile phone app analytics for cryptocurrency financial stock market analysis analyze graph trading data index investment growth chart on smartphone screen.

Dynavax Technologies Corporation (NASDAQ:DVAX) finished Wednesday with a subtraction of -$0.3 to close at $10.07, a downside of -2.89 percent. An average of 2,492,060 shares of common stock have been traded in the last five days. There was a fall of -$1.48 in the past week, and it reached a new high 4 times over the past 12 months. The last 20 days have seen an average of 1,940,690 shares traded, while the 50-day average volume stands at 2,178,124.

DVAX stock has decreased by -14.22% in the last month. The company shares reached their 1-month lowest point of $10.07 on 09/21/22. With the stock rallying to its 52-week high on 08/10/22, shares of the company touched a low of $7.26 and a high of $21.39 in 52 weeks. It has reached a new high 9 times so far this year and lost -28.43% or -$4.00 in price. In spite of this, the price is down -52.92% from the 52-week high.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


Insider Transactions

38 days have passed since Dynavax Technologies Corporation (DVAX) last reported insider trading activity. Hack Andrew A. F., who is Director, most recently acquired $3,000,000 shares at $14.68 per share on Aug 15. In this transaction, the insider spent $44,040,000. Senior Vice President, Janssen Robert, disposed of 7,938 shares at a price of $16.92 on Aug 09. The insider now owns more than $134,277 worth of shares. Prior to that, President & COO Novack David F went on to Sale 26,250 shares at $16.92 each on Aug 09. An amount of $444,037 was transacted.

Valuation Metrics

Dynavax Technologies Corporation (DVAX) has a trailing price-to-earnings (P/E) ratio of 7.51. The stock’s beta is 1.34. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 1.91, the price-to-book (PB) ratio at 3.01, and the price-to-cash flow ratio at 9.07.

Financial Health

The quick ratio of Dynavax Technologies Corporation for the three months ended June 29 was 2.60, and the current ratio was 2.80, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.52 and a total debt to equity ratio of 0.52 for the quarter ending June 29. Its gross profit as reported stood at $265.87 million compared to revenue of $439.44 million.

Earnings Surprise

For the three-month period that ended June 29, Dynavax Technologies Corporation had $269.08 million in cash. In the quarter under review, the net income was up than the previous quarter. The company posted a net income of $128.76 million in the quarter, while revenues of $32.86 million were grew 96.53%. The analyst consensus anticipated Dynavax Technologies Corporation’s latest quarter earnings to come in at $0.22 per share, but it turned out to be $0.87, a 295.50% surprise. For the quarter, EBITDA amounted to $129.91 million. Shareholders own equity worth $126.47 million.

Technical Picture

From a technical analysis perspective, let’s take a brief look at Dynavax Technologies Corporation (DVAX) price momentum. RSI 9-day as of the close on 21 September was 26.00%, suggesting the stock is oversold, with historical volatility in this time frame at 50.61%.

As of today, DVAX’s price is $10.79 -12.81% or -$1.48 from its 5-day moving average. DVAX is currently trading -14.22% lower than its 20-day SMA and +9.34% higher than its 100-day SMA. However, the stock’s current price level is -30.93% below the SMA50 and -23.54% below the SMA200.

The stochastic %K and %D were 24.19% and 29.93%, respectively, and the average true range (ATR) was 0.59. With the 14-day stochastic at 0.00% and the average true range at 0.62, the RSI (14) stands at 30.85%. The stock has reached -0.77 on the 9-day MACD Oscillator while the 14-day reading was at -0.80.


Please enter your comment!
Please enter your name here